Astrazeneca Luxembourg
AstraZeneca Luxembourg, a subsidiary of the global biopharmaceutical giant AstraZeneca, is headquartered in Luxembourg (LU) and operates extensively across Europe and beyond. Founded in 1999, the company has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular, renal, and respiratory diseases. AstraZeneca is renowned for its commitment to research and development, with a robust pipeline of unique therapies that address unmet medical needs. The company’s core products, including groundbreaking treatments like Tagrisso and Farxiga, exemplify its dedication to advancing healthcare. With a strong market position, AstraZeneca Luxembourg continues to achieve notable milestones, contributing significantly to global health and improving patient outcomes.
DitchCarbon Score
How does Astrazeneca Luxembourg's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astrazeneca Luxembourg's score of 56 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Astrazeneca Luxembourg's reported carbon emissions
AstraZeneca Luxembourg, headquartered in LU, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their current impact on climate change or their progress towards sustainability. However, the company is likely engaged in industry-standard climate commitments, which may include initiatives aimed at reducing carbon footprints and enhancing environmental sustainability. As the pharmaceutical sector increasingly focuses on climate action, AstraZeneca may align with broader industry goals to achieve net-zero emissions in the future. Further details on their specific commitments or initiatives would be necessary to provide a comprehensive overview of their climate strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Astrazeneca Luxembourg is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
